Previous 10 | Next 10 |
-Underwritten Public Offering and Nasdaq Listing Completed in September 2020 -Positive Phase 3 Interim Analysis Reported with an Estimated 37 percent More Recoveries Observed in the Lenzilumab Arm Versus Current Standard of Care Humanigen, Inc. , (HGEN)...
Greenland Technologies Holding (GTEC) +88% on launching integrated electric drivetrain.Trxade Group (MEDS) +70%.Summit Wireless Technologies (WISA) +42% on Q4 guidance.Mogo (MOGO) +27% on Q3 results.Fulgent Genetics (FLGT) +16% on Q3 results.Affime...
Gainers: Sundial Growers (SNDL) +79%.Aptevo Therapeutics (APVO) +60%.AMC Entertainment (AMC) +60%.Ashford Hospitality Trust (AHT) +58%.Cinemark Holdings (CNK) +56%.National CineMedia (NCMI) +48%.Tuniu (TOUR) +41%.EPR Properties (EPR) +41%.Dave & Buster's Entertainment (PLAY) +40%.Bro...
Pfizer and BioNTech's announcement that their COVID-19 vaccine candidate showed 90% efficacy based on a preliminary analysis of results from a pivotal study has stoked selling in therapy developers. If the higher-than-expected efficacy holds, herd immunity in the general population could pote...
Humanigen (HGEN) perks 11% after announcing positive interim Phase 3 data of lenzilumab in patients hospitalized with COVID-19.Lenzilumab had a clinically meaningful impact on patient recovery, with an estimated 37% more recoveries observed in the lenzilumab arm (HR of 1.37) vs. cur...
FTS International (FTSI) +67% after successful confirmation of plan of reorganization.Mogo (MOGO) +58% after announcing MogoSpend supports Apple Pay, Google Pay and Samsung Pay.GoPro (GPRO) +21% on Q3 results.Glu Mobile (GLUU) +17% on Q3 results.Aurora ...
Under the umbrella of Operation Warp Speed, Humanigen (HGEN) and a joint program unit within the U.S. Department Defense will collaborate with the Department of Health and Human Services' BARDA to develop lenzilumab, a monoclonal antibody designed to prevent and treat a potentially life-threa...
Interim data suggest clinically meaningful impact on patient recovery from COVID-19 with an estimated 37 percent more recoveries observed in lenzilumab arm of Phase 3 trial versus current standard of care Data safety monitoring board recommendation demonstrates the Phase 3 t...
Humanigen, Inc. , (Nasdaq:HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ by neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) wit...
Beasley Broadcast Group (BBGI) +54% on Q3 results.Alaska Communications Systems Group (ALSK) +56% after announcing agreement to be acquired by Macquarie Capital and GCM Grosvenor for $3.0 per share.JAKKS Pacific (JAKK) +18% on Q3 results.trivago N.V. (TRVG) +15%....
News, Short Squeeze, Breakout and More Instantly...
Williams Industrial Services Group Inc. (WLMSQ) is expected to report $-0.15 for Q3 2023 Cellcom Israel Limited (CELJF) is expected to report for quarter end 2023-09-30 Central Japan Railway Co ADR (CJPRY) is expected to report for Q2 2024 CW Petroleum Corp (CWPE) is expected to repor...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...